Atai Life Sciences Nv (ATAI)

Stock price, financials, and technical signals for Atai Life Sciences Nv (ATAI).

Twitter
Facebook
Email
FinancialsNews & SentimentProCandlestick ProbabilityElite

$1.31

-0.005

(-0.38%)

As of 04/04/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

ATAI Performance Snapshot

1-Week Chg

-10.88%

1-Month Chg

-15.76%

3-Month Chg

-25.99%

6-Month Chg

12.93%

1-Year Chg

-47.81%

Year-To-Date Chg

-18.13%

Beta 1-Year

1.94

Beta 5-Year

1.13

Volatility (10-Day)

8.03%

ATAI Technicals

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-04-04

$1.31

-$0.00 (-0.38%)

$1.30

$1.35

$1.25

$1.30

1.55M ($2.03M)

2025-04-03

$1.31

-$0.17 (-11.15%)

$1.36

$1.41

$1.31

$1.34

1.75M ($2.31M)

2025-04-02

$1.48

$0.24 (19.35%)

$1.27

$1.48

$1.27

$1.41

2.62M ($3.87M)

2025-04-01

$1.24

-$0.12 (-8.82%)

$1.36

$1.38

$1.22

$1.28

2.93M ($3.64M)

2025-03-31

$1.36

-$0.11 (-7.48%)

$1.41

$1.45

$1.36

$1.39

1.23M ($1.67M)

2025-03-28

$1.47

-$0.10 (-6.37%)

$1.55

$1.57

$1.46

$1.50

1.20M ($1.76M)

2025-03-27

$1.57

$0.10 (6.8%)

$1.45

$1.58

$1.45

$1.53

1.89M ($2.97M)

2025-03-26

$1.47

-$0.10 (-6.37%)

$1.54

$1.57

$1.42

$1.49

2.13M ($3.13M)

2025-03-25

$1.57

$0 (0%)

$1.66

$1.66

$1.50

$1.58

2.00M ($3.14M)

2025-03-24

$1.57

$0.12 (8.28%)

$1.48

$1.57

$1.47

$1.54

2.24M ($3.52M)

ATAI Financials

Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE

  • Cash and equivalents

    $17.50M

    -61.13%

  • Total assets

    $159.39M

    -45.69%

  • Total liabilities

    $42.83M

    -12.87%

  • Total investments

    $125.79M

    -47.08%

  • Shareholders' equity

    $116.30M

    -52.13%

  • Book value per share

    $0.72

    -49.97%

Income Statement

(USD)

2024 Q4

Y/Y CHANGE

  • Revenue

    -$5.00K

    -127.78%

  • Net income

    -$38.96M

    -112.98%

  • Operating expense

    $30.26M

    -9.88%

  • Gross profit

    -$5.00K

    -127.78%

  • EBITDA

    -$37.76M

    -126.26%

  • Earnings per share

    -$0.24

    -118.18%

Cash Flow

(USD)

2024 Q4

Y/Y CHANGE

  • Net change in cash

    -$17.46M

    44.50%

  • Cash from operations

    -$24.30M

    -10.62%

  • Cash from investing

    $6.56M

    897.08%

  • Cash from financing

    $154.00K

    101.82%

  • Free cash flow

    -$24.30M

    -10.56%

  • Free cash flow per share

    -$0.15

    -15.27%

Metrics

(USD)

2024 Q4

Y/Y CHANGE

  • Market capitalization

    $223.18M

    -4.66%

  • Enterprise value

    $217.02M

    24.54%

  • Shares outstanding

    167.80M

    1.08%

  • Profit margin

    779160.00%

    866.72%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    755200.00%

    914.52%

Dividends

(USD)

2024 Q4

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    3.21

    -65.19%

View All Financials